BZAR
BZAR (Rhodamine 110, bis-(N-CBZ-L-arginine amide), dihydrochloride) is a substrate for serine proteases (1-5) and is also an inhibitor for quanidinobenzoatase. It is 50 to 100 times more sensitive than the AMC-based substrate.
Wishlist updated! View wishlist
Product Description
BZAR (Rhodamine 110, bis-(N-CBZ-L-arginine amide), dihydrochloride) is a substrate for serine proteases (1-5) and is also an inhibitor for quanidinobenzoatase. It is 50 to 100 times more sensitive than the AMC-based substrate.
- λExλEmof end product (R110) = 496/520 nm
- Off-white to pink solid soluble in DMSO
- Store at 4°C and protect from light
- C48H52Cl2N10O9
- MW: 983.91
References
1. J Histochem Cytochem 49, 1473(2001).
2. Biotechniques 29, 1108-1113 (2000).
3. J Enzyme Inhib 6, 303(1992).
4. Biochem Soc Trans 18, 632 (1990).
5. J Cancer Res Clin Oncol 116, 57 (1990).
6. J Enzyme Inhib 2, 209 (1988).
You may also like…
Dual Apoptosis Assay with NucView® 488 Caspase-3 Substrate & Annexin V
These kits provides two apoptosis markers, our novel NucView® 488 Caspase-3 Substrate and Annexin V conjugate for detecting caspase-3 activation and phosphatidylserine (PS) translocation.
Staurosporine
Staurosporine is a potent and cell-permeable inhibitor of a wide variety of protein kinases by competing for the ATP binding site.